The research by Yin et al. revealed that ITGB1 can control the triple-negative breast cancer (TNBC) cells' invasion, migration, and treatment sensitivity and may be a predictive biomarker for the survival of TNBC patients. This evidence concerns the gene ITGB1 and triple-negative breast carcinoma.